Quantifying Glosair™ 400 efficacy for surface disinfection of American Type Culture Collection strains and micro-organisms recently isolated from intensive care unit patients

Journal of Hospital Infection

Volumn 87, Issue 3, 2014, Pages 175-178

  Herruzo, R ^a   Vizcaino M J ^a   Herruzo, I ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

Author keywords

Glosair ; Micro organisms from patients; Quantitative efficacy; Surfaces

Indexed keywords

HYDROGEN PEROXIDE; DISINFECTANT AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; DISINFECTION SYSTEM; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL CONTAMINATION; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIA; BACTERIAL COUNT; BACTERIAL INFECTION; DRUG EFFECTS; HUMAN; MICROBIOLOGY; YEAST;

BACTERIA; BACTERIAL INFECTIONS; COLONY COUNT, MICROBIAL; DISINFECTANTS; ENVIRONMENTAL MICROBIOLOGY; HUMANS; INTENSIVE CARE UNITS; YEASTS;

EID: 84903486177     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.04.006     Document Type: Article

References (9)

1. Otter A., Yezli S., French G.L. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011, 32:687-699.
2. Carling P.C., Parry M.F., Bruno-Murtha L.A., Dick B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med 2010, 38:1054-1059.
3. Huang S.S., Datta R., Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Archs Intern Med 2006, 166:1945-1951.
4. Nseir S., Blazejewski C., Lubret R., Wallet F., Courcol R., Durocher A. Risk of acquiring multidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011, 17:1201-1208.
5. Fu T.Y., Gent P., Kumar V. Efficacy, efficiency and safety aspect of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. JHosp Infect 2012, 80:199-205.
6. Davies A., Pottage T., Bennett A., Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. JHosp Infect 2011, 77:199-203.
7. Bartels M.D., Kristoffersen K., Slotsbjerg T., Rohde S.M., Lundgren B., Westh H. Environmental meticillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. JHosp Infect 2008, 70:35-41.
8. Grare M., Dailloux M., Simon L., Dimajo P., Laurain C. Efficacy of dry mist of hydrogen peroxide (DMHP) against Mycobacterium tuberculosis and use of DMHP for routine decontamination of biosafety level 3 laboratories. JClin Microbiol 2008, 46:2955-2958.
9. Herruzo-Cabrera R., Vizcaino-Alcaide M.J., Fernandez-Aceñero M.J. The influence of laboratory adaptation on test strains, such as P.aeruginosa, in the evaluation of the antimicrobial efficacy of ortho-phthalaldehyde. JHosp Infect 2004, 57:217-222.